Viridian Therapeutics, Inc. (VRDN)
33.26
+0.23
(+0.70%)
USD |
NASDAQ |
Jan 16, 16:00
33.20
-0.06
(-0.18%)
After-Hours: 20:00
Viridian Therapeutics Shareholders Equity (Annual): 671.64M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Marker Therapeutics, Inc. | 18.56M |
| Orthofix Medical, Inc. | 503.12M |
| ADMA Biologics, Inc. | 349.02M |
| Avantor, Inc. | 5.957B |
| Immunovant, Inc. | 707.45M |